The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing - Wikidata - awgldk - TriplyDB

The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing

The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing

http://www.wikidata.org/entity/Q24545914

about

Hypoxia-inducible C-to-U coding RNA editing downregulates SDHB in monocytes Purification of human double-stranded RNA-specific editase 1 (hRED1) involved in editing of brain glutamate receptor B pre-mRNA Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3' UTRs C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors Identification of the yeast cytidine deaminase CDD1 as an orphan C-->U RNA editase A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma Functions and regulation of the APOBEC family of proteins Neurofibromatosis type 1 (NF1): a protein truncation assay yielding identification of mutations in 73% of patients.Tissue-specific modification of gld-2 mRNA in C. elegans: likely C-to-U editing.Mitochondrial tRNAs in the lower fungus Spizellomyces punctatus: tRNA editing and UAG 'stop' codons recognized as leucine.The challenge of target sequence specificity in C-->U RNA editing.Apolipoprotein B RNA sequence 3' of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing.APOBEC-1-mediated RNA editing.Genetics of neurofibromatosis 1 and the NF1 gene.C-to-U RNA editing: mechanisms leading to genetic diversity.FAS mRNA editing in Human Systemic Lupus Erythematosus.Genetics of neurofibromatosis 1-associated peripheral nerve sheath tumors.Latent herpes simplex virus infection of sensory neurons alters neuronal gene expression.RNA editing in kinetoplastid protozoa Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease.When you can't trust the DNA: RNA editing changes transcript sequences.Apolipoprotein B mRNA-editing, catalytic polypeptide cytidine deaminases and retroviral restriction.The multifaceted roles of RNA binding in APOBEC cytidine deaminase functions.Identification of novel alternative splice variants of APOBEC-1 complementation factor with different capacities to support apolipoprotein B mRNA editing.Structural and functional assessment of APOBEC3G macromolecular complexes.The APOBEC Protein Family: United by Structure, Divergent in Function.Flow-cytometric visualization of C>U mRNA editing reveals the dynamics of the process in live cells.The RNA editing enzyme APOBEC1 induces somatic mutations and a compatible mutational signature is present in esophageal adenocarcinomas.RNA binding to APOBEC deaminases; Not simply a substrate for C to U editing.Nuclear Exclusion of the HIV-1 host defense factor APOBEC3G requires a novel cytoplasmic retention signal and is not dependent on RNA binding.Lack of Apobec2-related proteins causes a dystrophic muscle phenotype in zebrafish embryos Comparing methods of detection and quantitation of RNA editing of rat glycine receptor alpha3.Hippocampal Characteristics and Invariant Sequence Elements Distribution of GLRA2 and GLRA3 C-to-U Editing Letter from the editor: Adenosine-to-inosine RNA editing in Alu repeats in the human genome.Gene regulation by mRNA editing.Effects of cocaine and reserpine administration on RNA editing of rat 5-HT2C receptor estimated by primer extension combined with denaturing high-performance liquid chromatography.Low editing efficiency of GluR2 mRNA is associated with a low relative abundance of ADAR2 mRNA in white matter of normal human brain.RNA editing of interleukin-12 receptor beta2, 2451 C-to-U (Ala 604 Val) conversion, associated with atopy.RNA editing produces glycine receptor alpha3(P185L), resulting in high agonist potency.

P2860

Q21128745-5CFA760D-CA13-41B6-B4FF-6EC78BBAB0C1 Q24312651-3A66902C-2E3B-43A0-82D2-70B9874C013B Q24618983-10ACFC42-68F6-403E-A8D5-4CEA624F58BF Q24633130-CADC3D4A-4E05-4F83-AC21-8519E0734EE8 Q24680992-F78FCC01-73EB-458D-A34E-1B4FAE47FFCA Q27938986-683659A1-7B90-4650-A3A5-874517A85C67 Q30274830-3B83CD08-BC6F-4590-B2DC-162D848C2DF9 Q33595661-7639D118-0C99-4278-A120-3A1E874480DC Q33681371-0C9A84C1-BE5F-465E-B145-C238878B445E Q34365999-16E5A3DC-44BF-46B2-9D80-FDBA8C1DD0D6 Q34415068-9B8C4590-9B22-4CF1-B201-F916F1BFB2AA Q34517899-201D635B-9C97-4FD2-9E2B-B24027C0226C Q34660658-34ECA565-39EA-4751-B2F1-FC6E593DB12D Q34910421-385E3CB0-12F6-4A83-BB58-9B05610452A9 Q34982028-1501C105-0EB6-4104-B157-71CC54770C22 Q35006728-E70AB52A-819F-4519-ACC6-D3AA8982686C Q35387068-D8B2FFB7-C346-48FC-9854-B9E431B4317E Q35634817-A3CCE9FD-C84A-4360-949D-DE4769FCAE39 Q35803233-472FE1A3-FEF3-4D78-BF58-534D0042539C Q36574222-A7E7855E-84DE-4AB2-B2F5-076088EB446D Q36872209-9B1977E2-D8D5-4F4E-90AE-4685B6FB8AB1 Q37799569-508B8DB7-D5EF-49CE-8FE6-AA6F5F850B03 Q38006906-43AEFB17-FA0E-4992-AFCE-3CFEE7825136 Q38199065-62F9A60B-79F0-4243-BAAA-767F98D72C49 Q38348889-20F0E5B4-641C-4264-9454-82B85558DD21 Q38778847-351BCCD5-94EC-4DC4-8195-89CD7453798E Q38860803-E86F85FE-E3B5-409A-9E15-7D7F362DAC26 Q38895502-602FC640-FC98-4235-B92F-93FCC865FFD7 Q38969484-4027F78D-97A6-45EC-865E-41E74A0CD706 Q39015203-5E18E1C3-625A-4186-82F8-E857B4015267 Q40029354-5EAD6812-9D39-4EEE-AED1-EB0A2A2E5B28 Q40464531-9377A0B3-7049-4E55-B23E-D248B552F5ED Q42096824-82A99D52-154B-4A34-A490-AAE3A3B0B564 Q42211038-8387A60A-8738-4854-B42B-AD55A4441FF1 Q42554250-F835B3A4-4756-40B0-BD68-46339E8361BB Q43109064-C31AC210-57B1-486B-AAD5-1D9F7B4C5728 Q44221553-03903F55-C991-443A-935F-B61156D41CD0 Q44511945-7B6D171C-0030-43F5-BA88-6F0D664A93A6 Q44789663-4BB5EC09-0D48-4290-9382-CCF1440D8589 Q46491553-44332516-ABEE-4F93-942B-2B3BC76B647E

P2860

The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing

http://www.wikidata.org/entity/Q24545914

description

1996 nî lūn-bûn

@nan

1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing

@ast

The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing

@en

The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing

@nl

type

label

The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing

@ast

The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing

@en

The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing

@nl

prefLabel

The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing

@ast

The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing

@en

The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing

@nl

P1433

Q24545914-96F56524-1B1D-4CD1-9C9F-1DD8343AFD5A

P1476

Q24545914-0EE0BAE5-7BB9-4B77-839E-7F56F7E380F5

P2093

Q24545914-289B8AD3-1FAE-4F73-8280-450119075620

Q24545914-59D01DBD-0886-45B3-A0C4-3BCF6D681A28

Q24545914-839EBDC4-2FE7-43D4-9E32-E979D3CA34C0

Q24545914-9B3CE87A-89B1-4BB9-8B58-49EA33FE1779

Q24545914-B8CA80FE-2771-486C-B9DF-787F8D8C9C3A

P2860

Q24545914-01D82DB8-4049-4130-ABAC-87408CED9E7F

Q24545914-16986E01-1FB9-4CFC-9B7E-CF197041F624

Q24545914-1DA4D619-B05B-4190-AA9B-BDD7B13B17B3

Q24545914-2892B2D7-9C04-434D-B54D-8FB4C804375F

Q24545914-30086052-80C2-4B65-8D46-93C6794A88F9

Q24545914-3AE11E90-7E80-4995-AB81-CB0F74438FE5

Q24545914-3C0525E3-6C6B-48C7-BF8D-E6952CF3609A

Q24545914-4281733C-A771-48BC-BD12-390A64A3FB1B

Q24545914-4281BA02-DC01-4347-ABFB-E77C017E5F33

Q24545914-47F15517-60EB-4F49-8A4A-B52913057829

P304

Q24545914-E51782C2-E62E-4005-9C5F-399828C3F4E6

P31

Q24545914-21115FDA-062A-4476-B63D-F809DF7A6CBB

P356

Q24545914-CC6F9673-34F8-4B5B-8A42-49427B0B2D38

P407

Q24545914-C8E3C118-7C27-41F4-88FD-071B9793F981

P433

Q24545914-3AAF06E1-CA5B-45B7-9FA5-890D9E880B63

P478

Q24545914-AC733E6A-C128-4B8E-BB2C-72EDB858119A

P577

Q24545914-E3D6E6B0-D09F-4D27-993C-71E6A32B0CC8

P5875

Q24545914-BCE9AC32-2B6F-4524-93DB-04F02C47F50D

P698

Q24545914-61976D42-A838-4C18-9FBE-5D9237407C3C

P932

Q24545914-2C2A197E-49DE-49CF-A790-397E99542898

P356

P1433

Nucleic Acids Research

P1476

The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing

@en

P2093

A J Cappione

http://www.w3.org/2001/XMLSchema#string

G R Skuse

http://www.w3.org/2001/XMLSchema#string

H C Smith

http://www.w3.org/2001/XMLSchema#string

L J Metheny

http://www.w3.org/2001/XMLSchema#string

M Sowden

http://www.w3.org/2001/XMLSchema#string

P2860

DNA sequencing with chain-terminating inhibitors

Evolutionary origins of apoB mRNA editing: catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site

The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins

A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity

Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing

Intron sequence directs RNA editing of the glutamate receptor subunit GluR2 coding sequence

Mutation and cancer: statistical study of retinoblastoma

Three distinct RNA sequence elements are required for efficient apolipoprotein B (apoB) RNA editing in vitro

Induction of RNA editing at heterologous sites by sequences in apolipoprotein B mRNA

Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase

P304

478-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NAR/24.3.478

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

1996-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14598913

http://www.w3.org/2001/XMLSchema#string

P698

8602361

http://www.w3.org/2001/XMLSchema#string

P932

145654

http://www.w3.org/2001/XMLSchema#string